Andrey V. Sivkov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrey V. Sivkov has a total of 175 co-authors. Here are the top co-authors by number of shared publications:
- Oleg I. Apolikhin
N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
47 shared publications - Andrei Dmitrievich Kaprin
National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Koroleva St. 4, 249036 Obninsk, Russia
39 shared publications Russia Moscow
39 shared publications- Mikhail Yu. Prosyannikov
The department of urolithiasis of N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Centre of Radiology of Ministry of health of Russian Federation; Moscow, Russia
36 shared publications - Nikolay V. Anokhin
National Medical Research Radiological Center
29 shared publications - Dmitriy A. Voytko
N.A. Lopatkin Research Institute of Urology and Interventional Radiology – Branch of the National Medical Research Center of Radiology of the Ministry of Health of Russia
25 shared publications
Latest Publications
- 5 June 2026
- Published by Vidar, Ltd. in Medical Visualization
- Vol. 30 (2) , 56-67
Effect of ultrasound machine settings on twinkling artifact visualization
Study objective: Determination of optimal parameters of ultrasound scanning of urinary stones for effective visualization of Doppler twinkling artifact. Materials and Methods: A search of modern literature (from 2015 to 2025) devoted to the influence of ultrasound scanner settings on twinkling artifact visualization in Russian and English was conducted in the scientific databases Pubmed, Scopus and Elibrary. The influence of scanning parameters on the intensity of Doppler twinkling artifact visualization studied using a specially designed phantom, in which a calcium oxalate urinary stone with a diameter of 5 mm placed. The study performed on the following ultrasound machines: Philips Affinity 70, ALOKA ProSound F75, Canon Aplio i700, Siemens ACUSON NX3 Elite, GE Healthcare LOGIQ E9, Mindray DC-60 Pro X-Insight using a convex abdominal probe in Doppler mapping mode. The following ultrasound parameters were determined: Transmitter power, Color Doppler reference frequency, B-mode probe frequency, Focal length, Color window width, Harmonic, Pulse repetition frequency, Multibeam scanning, Color-write priority, Doppler signal gain (C-gain), B-mode gain (B-gain), Tissue harmonic mode, Interframe averaging, Color mapping averaging, Flash suppression, and Vessel wall oscillation filter. Results. The paper analyzes settings such as ultrasound frequency, signal gain level, and time setting parameters, clearly demonstrating how these factors affect image clarity and diagnostic accuracy. The following ultrasound scanner settings have been determined to increase twinkling artifact visualization efficiency: increasing the transmitter power to maximum; decreasing the color Doppler reference frequency; setting the focal zone below the object location depth; decreasing the color window width and increasing the pulse repetition rate. The influence of software solutions aimed at artifact suppression can be reduced by setting the priority to the color value; disabling flash suppression; increasing the wall filter values; disabling flash suppression and tissue harmonics. Conclusions. Optimization of ultrasound scanning parameters can significantly increase the efficiency of twinkling artifact detection in urinary stones.
- 5 June 2026
- Published by Vidar, Ltd. in Medical Visualization
- Vol. 30 (2) , 56-67
Effect of ultrasound machine settings on twinkling artifact visualization
Study objective: Determination of optimal parameters of ultrasound scanning of urinary stones for effective visualization of Doppler twinkling artifact. Materials and Methods: A search of modern literature (from 2015 to 2025) devoted to the influence of ultrasound scanner settings on twinkling artifact visualization in Russian and English was conducted in the scientific databases Pubmed, Scopus and Elibrary. The influence of scanning parameters on the intensity of Doppler twinkling artifact visualization studied using a specially designed phantom, in which a calcium oxalate urinary stone with a diameter of 5 mm placed. The study performed on the following ultrasound machines: Philips Affinity 70, ALOKA ProSound F75, Canon Aplio i700, Siemens ACUSON NX3 Elite, GE Healthcare LOGIQ E9, Mindray DC-60 Pro X-Insight using a convex abdominal probe in Doppler mapping mode. The following ultrasound parameters were determined: Transmitter power, Color Doppler reference frequency, B-mode probe frequency, Focal length, Color window width, Harmonic, Pulse repetition frequency, Multibeam scanning, Color-write priority, Doppler signal gain (C-gain), B-mode gain (B-gain), Tissue harmonic mode, Interframe averaging, Color mapping averaging, Flash suppression, and Vessel wall oscillation filter. Results. The paper analyzes settings such as ultrasound frequency, signal gain level, and time setting parameters, clearly demonstrating how these factors affect image clarity and diagnostic accuracy. The following ultrasound scanner settings have been determined to increase twinkling artifact visualization efficiency: increasing the transmitter power to maximum; decreasing the color Doppler reference frequency; setting the focal zone below the object location depth; decreasing the color window width and increasing the pulse repetition rate. The influence of software solutions aimed at artifact suppression can be reduced by setting the priority to the color value; disabling flash suppression; increasing the wall filter values; disabling flash suppression and tissue harmonics. Conclusions. Optimization of ultrasound scanning parameters can significantly increase the efficiency of twinkling artifact detection in urinary stones.
- Open Access
- 1 June 2026
- Published by Non-profit partnership "Professional Association of Andrologists" in Andrology and Genital Surgery
- Vol. 26 (2) , 60-70
Prevention of gonadotoxicity of the chemotherapy drug cisplatin by stem cell secretom therapy
Introduction. Chemotherapy is one of the main methods of treating common/metastatic forms of malignant diseases. A commonly used chemotherapy drug is Cisplatin, a significant side effect of which is a toxic effect on organs with high proliferative potential, including the testicles, which can lead to severe disorders of spermatogenesis, androgen deficiency and infertility. The aim of the study. To study the possibility of preventing Cisplatin gonadotoxicity using Cellex therapy, which refers to drugs containing products of stem cell secretion. Materials and methods. Experiments were conducted on 45 male mongrel rats: Series 1 – intraperitoneal cisplatin administration at a dose of 5 mg/ kg, Series 2 – cisplatin administration at a dose of 7 mg/ kg, Series 3 – cisplatin administration at a dose of 5 mg/ kg during therapy with Cellex (0.1 mg/ kg intramuscularly daily for 10 days), 4 series – the introduction of Cisplatin at a dose of 7 mg / kg with Cellex therapy as in 3 series. After 3, 7, and 14 days, the concentration of testosterone in the blood was determined, and after 14 days, the testicles were removed, followed by their histological and morphometric examination. Results. In the 1st and 2nd series, the development of testicular hypoplasia with a decrease in their mass by 15% was revealed with pronounced disorders of spermatogenesis, manifested in a decrease in the diameter and cross-sectional area of the seminal tubules, layers of the germinal epithelium and the number of Sertoli cells per 100 mcm of the basement membrane. At the same time, in the 2nd series, the appearance of destroyed tubules and groups of tubules completely devoid of epithelial lining was revealed. In the 3rd and 4th series, the histological picture approached normal, although the morphometric parameters still did not reach normal values. In group 4, the proportion of destroyed and emptied tubules was significantly less than in group 2. The level of testosterone in the blood of rats decreased starting from day 3 in group 1 and on day 1 in group 2 and remained significantly reduced until the end of the follow-up, whereas in groups 3 and 4 it remained within normal limits at all times. Conclusion. Cellex therapy can significantly reduce the toxic effect of Cisplatin on the testicle, while maintaining active spermatogenesis and testosterone synthesis. Keywords: chemotherapy, cisplatin, spermatogenesis disorder, testosterone, cell therapy, cellex.
- 1 June 2026
- Published by Non-profit partnership "Professional Association of Andrologists" in Andrology and Genital Surgery
- Vol. 26 (2) , 60-70
Open AccessPrevention of gonadotoxicity of the chemotherapy drug cisplatin by stem cell secretom therapy
Introduction. Chemotherapy is one of the main methods of treating common/metastatic forms of malignant diseases. A commonly used chemotherapy drug is Cisplatin, a significant side effect of which is a toxic effect on organs with high proliferative potential, including the testicles, which can lead to severe disorders of spermatogenesis, androgen deficiency and infertility. The aim of the study. To study the possibility of preventing Cisplatin gonadotoxicity using Cellex therapy, which refers to drugs containing products of stem cell secretion. Materials and methods. Experiments were conducted on 45 male mongrel rats: Series 1 – intraperitoneal cisplatin administration at a dose of 5 mg/ kg, Series 2 – cisplatin administration at a dose of 7 mg/ kg, Series 3 – cisplatin administration at a dose of 5 mg/ kg during therapy with Cellex (0.1 mg/ kg intramuscularly daily for 10 days), 4 series – the introduction of Cisplatin at a dose of 7 mg / kg with Cellex therapy as in 3 series. After 3, 7, and 14 days, the concentration of testosterone in the blood was determined, and after 14 days, the testicles were removed, followed by their histological and morphometric examination. Results. In the 1st and 2nd series, the development of testicular hypoplasia with a decrease in their mass by 15% was revealed with pronounced disorders of spermatogenesis, manifested in a decrease in the diameter and cross-sectional area of the seminal tubules, layers of the germinal epithelium and the number of Sertoli cells per 100 mcm of the basement membrane. At the same time, in the 2nd series, the appearance of destroyed tubules and groups of tubules completely devoid of epithelial lining was revealed. In the 3rd and 4th series, the histological picture approached normal, although the morphometric parameters still did not reach normal values. In group 4, the proportion of destroyed and emptied tubules was significantly less than in group 2. The level of testosterone in the blood of rats decreased starting from day 3 in group 1 and on day 1 in group 2 and remained significantly reduced until the end of the follow-up, whereas in groups 3 and 4 it remained within normal limits at all times. Conclusion. Cellex therapy can significantly reduce the toxic effect of Cisplatin on the testicle, while maintaining active spermatogenesis and testosterone synthesis. Keywords: chemotherapy, cisplatin, spermatogenesis disorder, testosterone, cell therapy, cellex.
- 25 March 2026
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 19 (1)
Assessment of bone mineral density according to computed tomography in patients with urolithiasis.
Introduction. The incidence of urolithiasis associated with impaired bone density is increasing in Russia. Computed tomography (CT) is used to diagnose urolithiasis but does not routinely allow direct assessment of bone mineral density. A method of asynchronous quantitative computed tomography with phantom has been proposed, which enables automated assessment. Objective. To evaluate the bone mineral density of vertebral bodies in patients with urolithiasis using computed tomography data. Materials and methods. The automatic evaluation was performed by the Ka-Med hardware and software package. The Ka-Med includes a phantom for asynchronous calibration of the CT scanner and software. The phantom simulates the lumbar spine with varying concentrations of potassium hydrophosphate solution: the volumetric bone mineral density ranging from «osteoporosis» to «normal». The phantom scan data was uploaded to the software. In the software calibration curve was automatically constructed for conversion from X-ray density (HU) to bone mineral density (mg/ml). Bone mineral density was assessed in 65 patients diagnosed with urolithiasis according to the American College of Radiology 2023 criteria and compared with normative data from the University of California. Results. It was found that 7 patients had bone mineral density corresponded to osteoporosis, 27 patients had osteopenia and 31 patients were normal bone mineral density. Bone mineral density was significantly lower compared to normative data: in men (-1.05; p<0.001) and in women (-0.49; p<0.008). Conclusion. An automatic assessment of the mineral density of vertebral bodies in patients with urolithiasis was performed using computed tomography data. A significant decrease in bone mineral density relative to normative data was observed.
- 25 March 2026
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 19 (1)
Assessment of bone mineral density according to computed tomography in patients with urolithiasis.
Introduction. The incidence of urolithiasis associated with impaired bone density is increasing in Russia. Computed tomography (CT) is used to diagnose urolithiasis but does not routinely allow direct assessment of bone mineral density. A method of asynchronous quantitative computed tomography with phantom has been proposed, which enables automated assessment. Objective. To evaluate the bone mineral density of vertebral bodies in patients with urolithiasis using computed tomography data. Materials and methods. The automatic evaluation was performed by the Ka-Med hardware and software package. The Ka-Med includes a phantom for asynchronous calibration of the CT scanner and software. The phantom simulates the lumbar spine with varying concentrations of potassium hydrophosphate solution: the volumetric bone mineral density ranging from «osteoporosis» to «normal». The phantom scan data was uploaded to the software. In the software calibration curve was automatically constructed for conversion from X-ray density (HU) to bone mineral density (mg/ml). Bone mineral density was assessed in 65 patients diagnosed with urolithiasis according to the American College of Radiology 2023 criteria and compared with normative data from the University of California. Results. It was found that 7 patients had bone mineral density corresponded to osteoporosis, 27 patients had osteopenia and 31 patients were normal bone mineral density. Bone mineral density was significantly lower compared to normative data: in men (-1.05; p<0.001) and in women (-0.49; p<0.008). Conclusion. An automatic assessment of the mineral density of vertebral bodies in patients with urolithiasis was performed using computed tomography data. A significant decrease in bone mineral density relative to normative data was observed.
- Open Access
- 20 March 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (1) , 30-38
Impact of lipid intake on lithogenic metabolic parameters in urolithiasis
BACKGROUND: The global incidence of urolithiasis and obesity has been increasing, particularly in countries adopting a Western lifestyle. However, the role of dietary lipids in the development of urolithiasis remains insufficiently studied. AIM: This work aimed to assess the impact of total fat, saturated fatty acids, and cholesterol intake on biochemical parameters of lithogenic metabolism in patients with urolithiasis. METHODS: For a comprehensive assessment of dietary patterns, patients with urolithiasis were surveyed using an original questionnaire program. The questionnaire addressed the consumption of various food groups. Data on the chemical composition of foods were obtained from publicly available sources. Daily intake of fats, saturated fatty acids, and cholesterol was calculated based on reported consumption. Foods consumed more than once per month were included in the analysis. To evaluate lithogenic metabolism, serum and 24-hour urine levels of total calcium, phosphorus, urea, creatinine, chloride, magnesium, and uric acid were measured. The mineral composition of urinary calculi was determined by infrared spectroscopy using a reference spectral library of known stone composition. Patients were stratified according to stone composition (calcium oxalate, uric acid, and calcium phosphate). Comparative analysis of the mean intake of the studied nutrients and the associations between intake levels of fats, saturated fatty acids, and cholesterol and biochemical parameters of blood and urine was performed in these patient groups. Statistical analysis was conducted using Statistica 12.0 (StatSoft, USA) with parametric methods, including correlation analysis and the Student t test for independent samples. A significance level of p ≤ 0.05 was applied. RESULTS: A total of 140 patients with urolithiasis were included: 67 men (47.9%) and 73 women (52.1%), aged 19 to 73 years. Stone composition was determined in all patients: calcium oxalate stones in 68 (48.6%), uric acid stones in 18 (12.9%), calcium phosphate stones in 44 (31.4%), and struvite stones in 10 (7.1%). In the overall cohort, mean intake of saturated fatty acids and cholesterol exceeded recommended levels: 37.82 ± 1.23 g and 347.98 ± 13.95 mg per day, respectively. No differences in intake between men and women were observed. High cholesterol intake had the greatest impact on metabolic parameters across most stone types. CONCLUSIONS: Lipid intake may influence lithogenic metabolism depending on the chemical composition of urinary stones. When prescribing dietary interventions aimed at reducing intake of fats, saturated fatty acids, and cholesterol, the chemical composition of urinary stones should be taken into account.
- 20 March 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (1) , 30-38
Open AccessImpact of lipid intake on lithogenic metabolic parameters in urolithiasis
BACKGROUND: The global incidence of urolithiasis and obesity has been increasing, particularly in countries adopting a Western lifestyle. However, the role of dietary lipids in the development of urolithiasis remains insufficiently studied. AIM: This work aimed to assess the impact of total fat, saturated fatty acids, and cholesterol intake on biochemical parameters of lithogenic metabolism in patients with urolithiasis. METHODS: For a comprehensive assessment of dietary patterns, patients with urolithiasis were surveyed using an original questionnaire program. The questionnaire addressed the consumption of various food groups. Data on the chemical composition of foods were obtained from publicly available sources. Daily intake of fats, saturated fatty acids, and cholesterol was calculated based on reported consumption. Foods consumed more than once per month were included in the analysis. To evaluate lithogenic metabolism, serum and 24-hour urine levels of total calcium, phosphorus, urea, creatinine, chloride, magnesium, and uric acid were measured. The mineral composition of urinary calculi was determined by infrared spectroscopy using a reference spectral library of known stone composition. Patients were stratified according to stone composition (calcium oxalate, uric acid, and calcium phosphate). Comparative analysis of the mean intake of the studied nutrients and the associations between intake levels of fats, saturated fatty acids, and cholesterol and biochemical parameters of blood and urine was performed in these patient groups. Statistical analysis was conducted using Statistica 12.0 (StatSoft, USA) with parametric methods, including correlation analysis and the Student t test for independent samples. A significance level of p ≤ 0.05 was applied. RESULTS: A total of 140 patients with urolithiasis were included: 67 men (47.9%) and 73 women (52.1%), aged 19 to 73 years. Stone composition was determined in all patients: calcium oxalate stones in 68 (48.6%), uric acid stones in 18 (12.9%), calcium phosphate stones in 44 (31.4%), and struvite stones in 10 (7.1%). In the overall cohort, mean intake of saturated fatty acids and cholesterol exceeded recommended levels: 37.82 ± 1.23 g and 347.98 ± 13.95 mg per day, respectively. No differences in intake between men and women were observed. High cholesterol intake had the greatest impact on metabolic parameters across most stone types. CONCLUSIONS: Lipid intake may influence lithogenic metabolism depending on the chemical composition of urinary stones. When prescribing dietary interventions aimed at reducing intake of fats, saturated fatty acids, and cholesterol, the chemical composition of urinary stones should be taken into account.
- Open Access
- 29 January 2026
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 16 (4)
A method for assessing split renal function in computed tomography: a retrospective study
INTRODUCTION: Accurate determination of the percentage of Renal contribution to their overall function is an important indicator when choosing clinical tactics for Renal transplantation and surgical interventions. The possibility of using nephroscintigraphy or complex alternative radiation methods is not always available. OBJECTIVE: Development and validation of methods for assessing split Renal function in a standard CT scan with contrast based on specialized automatic segmentation programs or manual measurement data. MATERIAL AND METHODS: The study included the results of a CT scan of the retroperitoneal space with contrast in 243 patients. 100 of them had nephroscintigraphy data. The Vitrea Advanced Visualization software was used for automatic segmentation of the renal parenchyma into the nephrographic phase. Data on volume ( V ) and average density ( HU ) were obtained. The values of renal parenchyma density in the native phase were performed manually. The split contribution of the Renals was determined based on the percentage ratio of the «mass» of the contrast agent in the parenchyma of each Renal, calculated as the product of the volume of the parenchyma and the average values of its density. The obtained results were compared with the nephroscintigraphy data. To develop a manual method for calculating the volume of the renal parenchyma, three linear Renal sizes (width, thickness, and length) and three parenchymal thicknesses were measured. The average values of renal parenchyma density were obtained based on three measurements of the round ROI at different levels. Statistics: The results obtained during the study were processed using statistical evaluation methods (correlation and covariance analysis). RESULTS: Using data on the volume values of the Renal parenchyma obtained during automatic segmentation using regression analysis, formulas for calculating the volume of the parenchyma were obtained based on taking into account all six linear Renal sizes with additional coefficients: V =1/1000(0.92 xyT –0.07 y 3 +0.07 yz 2 +0.19 z 2 T ), which demonstrated a high positive correlation and accuracy of the method (correlation coefficient — 0,99 (pDISCUSSION: The conducted studies have confirmed the high effectiveness of the two proposed methods for assessing separate kidney function based on standard CT with contrast. The automated method demonstrated a very high correlation with the results of dynamic nephroscintigraphy. This opens up the prospect of replacing radionuclide testing in a number of clinical situations, which will reduce radiation exposure and simplify patient examination. An alternative manual method based on linear measurements of the kidney and the density of its parenchyma also showed high accuracy. The method is a clinically valuable solution for medical institutions that do not have expensive specialized 3D segmentation software. CONCLUSIONS: The developed automated method of segmentation of the renal parenchyma and an alternative method based on manual measurement make it possible to obtain data on split renal function during a routine CT scan with contrast without additional radiation and financial burden on the patient.
- 29 January 2026
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 16 (4)
Open AccessA method for assessing split renal function in computed tomography: a retrospective study
INTRODUCTION: Accurate determination of the percentage of Renal contribution to their overall function is an important indicator when choosing clinical tactics for Renal transplantation and surgical interventions. The possibility of using nephroscintigraphy or complex alternative radiation methods is not always available. OBJECTIVE: Development and validation of methods for assessing split Renal function in a standard CT scan with contrast based on specialized automatic segmentation programs or manual measurement data. MATERIAL AND METHODS: The study included the results of a CT scan of the retroperitoneal space with contrast in 243 patients. 100 of them had nephroscintigraphy data. The Vitrea Advanced Visualization software was used for automatic segmentation of the renal parenchyma into the nephrographic phase. Data on volume ( V ) and average density ( HU ) were obtained. The values of renal parenchyma density in the native phase were performed manually. The split contribution of the Renals was determined based on the percentage ratio of the «mass» of the contrast agent in the parenchyma of each Renal, calculated as the product of the volume of the parenchyma and the average values of its density. The obtained results were compared with the nephroscintigraphy data. To develop a manual method for calculating the volume of the renal parenchyma, three linear Renal sizes (width, thickness, and length) and three parenchymal thicknesses were measured. The average values of renal parenchyma density were obtained based on three measurements of the round ROI at different levels. Statistics: The results obtained during the study were processed using statistical evaluation methods (correlation and covariance analysis). RESULTS: Using data on the volume values of the Renal parenchyma obtained during automatic segmentation using regression analysis, formulas for calculating the volume of the parenchyma were obtained based on taking into account all six linear Renal sizes with additional coefficients: V =1/1000(0.92 xyT –0.07 y 3 +0.07 yz 2 +0.19 z 2 T ), which demonstrated a high positive correlation and accuracy of the method (correlation coefficient — 0,99 (pDISCUSSION: The conducted studies have confirmed the high effectiveness of the two proposed methods for assessing separate kidney function based on standard CT with contrast. The automated method demonstrated a very high correlation with the results of dynamic nephroscintigraphy. This opens up the prospect of replacing radionuclide testing in a number of clinical situations, which will reduce radiation exposure and simplify patient examination. An alternative manual method based on linear measurements of the kidney and the density of its parenchyma also showed high accuracy. The method is a clinically valuable solution for medical institutions that do not have expensive specialized 3D segmentation software. CONCLUSIONS: The developed automated method of segmentation of the renal parenchyma and an alternative method based on manual measurement make it possible to obtain data on split renal function during a routine CT scan with contrast without additional radiation and financial burden on the patient.
- 25 December 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (4)
The efficacy of alfuzosin and solifenacin combination in BPH patients with overactive bladder and low flowrate.
Introduction. The alfuzosin and solifenacin combination has previously demonstrated high efficacy and safety in patients with BPH and overactive bladder (OAB), including with severe LUTS, if cases of mechanical type of bladder outlet obstruction (BOO) were excluded. The present study aim was to confirm the efficacy and safety of such combination therapy in patients with severe urinary disorders according to uroflowmetry (UFM). Materials and methods. The observational multicenter AVIATOR study included 208 men with BPH and OAB. Its unique features were: the use of alfuzosin (Alfuprost® MR, 10 mg/day) and solifenacin (Vesigamp, 5 mg/day) combination for 3 months in patients with moderate to severe LUTS; intravesical prostatic protrusion ≥ 10 mm as exclusion criteria; comprehensive assessment of symptoms dynamics by IPSS/QoL, OABSS, PPIUS questionnaires; initial stratification of patients subgroups by Qmax; assessment of changes by UFM report and curve; evaluation of treatment efficacy by «clinically significant response» achieving. Results. Initially, patients were divided into two subgroups, depending on Qmax index: PG1 with Qmax < 12 ml/day (n=102); PG2 with Qmax ≥ 12 ml/day (n=106). PG1 and PG2 patients did not significantly differ in average age (60.2 and 61.3 years) and anthropometric data, but statistically differed in prostate volume (52.1+13.3 and 47.7+10.3 cm cc), total IPSS score, voiding symptoms (IPSS-v), OABSS and UFM parameters. At the same time, there were no significant differences in filling phase symptoms (IPSS-s), including nocturia, QoL, and PPIUS urgency. As a result of treatment, after one and three months, the patients majority in PG1 and PG2 achieved statistically significant improvement in most subjective and objective clinical indicators, respectively: IPSS by 45.2% and 70.5% versus 46.0% and 74.3%; IPSS-s by 42.7% and 70.1% vs. 47.2% and 74.7%; IPSS-v by 45.8% and 70.0% vs. 44.8% and 74.0%; QoL by 43.7% and 81.2% vs. 54.2% and 81.2%; OABSS by 48.6% and 78.9% vs. 53.5% and 82.0%; PPIUS by 50.0% and 84.6% vs. 54.2% and 87.5%; Qmax by 42.3% and 74.2% vs. 25.8% and 37.1%; Qave by 31.0% and 50.0% vs. 20.5% and 28.8%; the volume of urination increased by 3.4% and 10.0% versus 5.0% and 3.5%; the volume of residual urine increased by 50.9% and 76.8% versus 47.9% and 74.2%. At the same time, after 3 months of treatment, 36.3% of men in PG1 and 51.9% in PG2 demonstrated the normal shape of UFM curve. After one and three months in PG1 and PG2: the total IPSS score decreased for > 25% in 87.2% and 90.6% versus 98.0% and 100.0%; Qmax increased for > 30% in 55.9% and 15.1% versus 92.2% and 50.0%, due to a different «starting base» and achievement of normal Qmax values in PG2 after only one month of treatment. The combined treatment has demonstrated a high safety level. Conclusion. The study showed high efficacy and safety of alfuzosin and solifenacin combination therapy in patients with LUTS/BPH and OAB with moderate to severe urinary disorders according to UFM. The success of the treatment was achieved due to the use of an effective combination of drugs and the correct selection of patients for treatment with the exclusion of mechanical BOO cases from the program.
- 25 December 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (4)
The efficacy of alfuzosin and solifenacin combination in BPH patients with overactive bladder and low flowrate.
Introduction. The alfuzosin and solifenacin combination has previously demonstrated high efficacy and safety in patients with BPH and overactive bladder (OAB), including with severe LUTS, if cases of mechanical type of bladder outlet obstruction (BOO) were excluded. The present study aim was to confirm the efficacy and safety of such combination therapy in patients with severe urinary disorders according to uroflowmetry (UFM). Materials and methods. The observational multicenter AVIATOR study included 208 men with BPH and OAB. Its unique features were: the use of alfuzosin (Alfuprost® MR, 10 mg/day) and solifenacin (Vesigamp, 5 mg/day) combination for 3 months in patients with moderate to severe LUTS; intravesical prostatic protrusion ≥ 10 mm as exclusion criteria; comprehensive assessment of symptoms dynamics by IPSS/QoL, OABSS, PPIUS questionnaires; initial stratification of patients subgroups by Qmax; assessment of changes by UFM report and curve; evaluation of treatment efficacy by «clinically significant response» achieving. Results. Initially, patients were divided into two subgroups, depending on Qmax index: PG1 with Qmax < 12 ml/day (n=102); PG2 with Qmax ≥ 12 ml/day (n=106). PG1 and PG2 patients did not significantly differ in average age (60.2 and 61.3 years) and anthropometric data, but statistically differed in prostate volume (52.1+13.3 and 47.7+10.3 cm cc), total IPSS score, voiding symptoms (IPSS-v), OABSS and UFM parameters. At the same time, there were no significant differences in filling phase symptoms (IPSS-s), including nocturia, QoL, and PPIUS urgency. As a result of treatment, after one and three months, the patients majority in PG1 and PG2 achieved statistically significant improvement in most subjective and objective clinical indicators, respectively: IPSS by 45.2% and 70.5% versus 46.0% and 74.3%; IPSS-s by 42.7% and 70.1% vs. 47.2% and 74.7%; IPSS-v by 45.8% and 70.0% vs. 44.8% and 74.0%; QoL by 43.7% and 81.2% vs. 54.2% and 81.2%; OABSS by 48.6% and 78.9% vs. 53.5% and 82.0%; PPIUS by 50.0% and 84.6% vs. 54.2% and 87.5%; Qmax by 42.3% and 74.2% vs. 25.8% and 37.1%; Qave by 31.0% and 50.0% vs. 20.5% and 28.8%; the volume of urination increased by 3.4% and 10.0% versus 5.0% and 3.5%; the volume of residual urine increased by 50.9% and 76.8% versus 47.9% and 74.2%. At the same time, after 3 months of treatment, 36.3% of men in PG1 and 51.9% in PG2 demonstrated the normal shape of UFM curve. After one and three months in PG1 and PG2: the total IPSS score decreased for > 25% in 87.2% and 90.6% versus 98.0% and 100.0%; Qmax increased for > 30% in 55.9% and 15.1% versus 92.2% and 50.0%, due to a different «starting base» and achievement of normal Qmax values in PG2 after only one month of treatment. The combined treatment has demonstrated a high safety level. Conclusion. The study showed high efficacy and safety of alfuzosin and solifenacin combination therapy in patients with LUTS/BPH and OAB with moderate to severe urinary disorders according to UFM. The success of the treatment was achieved due to the use of an effective combination of drugs and the correct selection of patients for treatment with the exclusion of mechanical BOO cases from the program.
- 25 December 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (4)
Development of a method for assessing split Renal function in CT without using specialized workstations for their segmentation.
Introduction. Assessment of separate renal function is an important diagnostic characteristic when planning kidney transplant operations or significant surgical interventions. Modern methods make it possible to obtain such data with the help of additional studies, in particular with nephroscintigraphy, which carries with it an additional financial burden and an increase in preoperative preparation time. The developed methods for assessing the separate function of the kidneys due to their automatic segmentation during CT require specialized workstations. Purpose: development of a method for assessing separate renal function in a standard CT scan with contrast based on a new method for determining the volume of the renal parenchyma by individual linear dimensions and its densitometric parameters obtained by manual measurement. Materials and methods. The results of 120 CT scans of the abdominal cavity and retroperitoneal space with contrast have been retrospectively analyzed. In order to obtain data on the "true" volume of the kidneys and their average density values in Hounsfield units, the kidneys were segmented into the nephrographic phase of contrast on a workstation using the Vitrea Advanced Visualization program. To further develop a rational approach to determining the methodology for estimating kidney volume based on manual measurements, three linear kidney sizes and three parenchymal thicknesses most used in practical work were selected and measured. Based on the data obtained, a regression analysis was performed with various combinations of its linear dimensions. To evaluate the optimal method for determining the densitometric parameters of the renal parenchyma, they were measured with a circular ROI on axial sections in three kidney sections. The average values obtained were compared with those obtained by tracing the kidney parenchyma in the frontal section. Based on the calculated data of the kidney volume and densitometric parameters of the renal parenchyma, the separate contribution of the kidneys to their overall function was calculated. The calculation results were compared with similar data obtained during kidney segmentation in the nephrographic phase of contrast on the workstation during their automatic segmentation. Results. Regression analysis was used to obtain formulas for calculating parenchymal volume based on various combinations of its linear dimensions. Naturally, the formula that takes into account all six kidney sizes proved to be the most accurate: V=1/1000(0,92xyT-0,07y3+0,07yz2+0,19z2T). As a result of comparing two methods for estimating the average values of the densitometric parameters of the kidney parenchyma – using round ROI measurement and using manual circling – the round ROI measurement method was chosen, which showed the greatest correlation and covariance with similar data obtained with automatic kidney segmentation (the correlation coefficient was 0.988 (p<0.001); the covariance coefficient was 0.76 (p<0.001). The final analysis of the separate contribution of each kidney to their overall function based on the developed formula for manually calculating parenchymal volume and taking into account densitometric characteristics based on three measurements of parenchyma by round ROI demonstrated a high positive correlation with the results of calculating the separate contribution of each kidney obtained by automatic segmentation on a workstation. (correlation coefficient – 0.91 (p<0.001); covariance coefficient – 0.86 (p<0.001)). Conclusions. The developed methods for manually determining the volume of the renal parenchyma and estimating the density characteristics of the renal parenchyma with round ROI showed a very high correlation with similar data obtained with automatic kidney segmentation. These methods are convenient in practical work and do not require special software tools. The combined use of the developed methods will in many cases avoid the need for additional nephroscintigraphy and reduce the time needed to prepare the patient for treatment.
- 25 December 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (4)
Development of a method for assessing split Renal function in CT without using specialized workstations for their segmentation.
Introduction. Assessment of separate renal function is an important diagnostic characteristic when planning kidney transplant operations or significant surgical interventions. Modern methods make it possible to obtain such data with the help of additional studies, in particular with nephroscintigraphy, which carries with it an additional financial burden and an increase in preoperative preparation time. The developed methods for assessing the separate function of the kidneys due to their automatic segmentation during CT require specialized workstations. Purpose: development of a method for assessing separate renal function in a standard CT scan with contrast based on a new method for determining the volume of the renal parenchyma by individual linear dimensions and its densitometric parameters obtained by manual measurement. Materials and methods. The results of 120 CT scans of the abdominal cavity and retroperitoneal space with contrast have been retrospectively analyzed. In order to obtain data on the "true" volume of the kidneys and their average density values in Hounsfield units, the kidneys were segmented into the nephrographic phase of contrast on a workstation using the Vitrea Advanced Visualization program. To further develop a rational approach to determining the methodology for estimating kidney volume based on manual measurements, three linear kidney sizes and three parenchymal thicknesses most used in practical work were selected and measured. Based on the data obtained, a regression analysis was performed with various combinations of its linear dimensions. To evaluate the optimal method for determining the densitometric parameters of the renal parenchyma, they were measured with a circular ROI on axial sections in three kidney sections. The average values obtained were compared with those obtained by tracing the kidney parenchyma in the frontal section. Based on the calculated data of the kidney volume and densitometric parameters of the renal parenchyma, the separate contribution of the kidneys to their overall function was calculated. The calculation results were compared with similar data obtained during kidney segmentation in the nephrographic phase of contrast on the workstation during their automatic segmentation. Results. Regression analysis was used to obtain formulas for calculating parenchymal volume based on various combinations of its linear dimensions. Naturally, the formula that takes into account all six kidney sizes proved to be the most accurate: V=1/1000(0,92xyT-0,07y3+0,07yz2+0,19z2T). As a result of comparing two methods for estimating the average values of the densitometric parameters of the kidney parenchyma – using round ROI measurement and using manual circling – the round ROI measurement method was chosen, which showed the greatest correlation and covariance with similar data obtained with automatic kidney segmentation (the correlation coefficient was 0.988 (p<0.001); the covariance coefficient was 0.76 (p<0.001). The final analysis of the separate contribution of each kidney to their overall function based on the developed formula for manually calculating parenchymal volume and taking into account densitometric characteristics based on three measurements of parenchyma by round ROI demonstrated a high positive correlation with the results of calculating the separate contribution of each kidney obtained by automatic segmentation on a workstation. (correlation coefficient – 0.91 (p<0.001); covariance coefficient – 0.86 (p<0.001)). Conclusions. The developed methods for manually determining the volume of the renal parenchyma and estimating the density characteristics of the renal parenchyma with round ROI showed a very high correlation with similar data obtained with automatic kidney segmentation. These methods are convenient in practical work and do not require special software tools. The combined use of the developed methods will in many cases avoid the need for additional nephroscintigraphy and reduce the time needed to prepare the patient for treatment.
- 25 December 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (4)
Metabolic risk factors and urinary stones formation. XI: magnesiuria lithogenic features in men and women.
Introduction. The role of magnesiuria as a metabolic factor in the lithogenesis of both calcium stones and separately oxalate and phosphate urinary stones, as well as stones of other metabolic types, remains unclear. In this work, we investigated the effect of the degree of magnesium excretion in men and women with urolithiasis on metabolic parameters and the frequency of detection of urinary stones of various chemical compositions. Materials and methods. 865 stone formers (392 men and 473 women aged 18 to 79 years) were examined. To assess the lithogenic activity of magnesiuria in stone formers men and women, the values of magnesium excretion (in mmol/day) were ranked in ascending order and divided into 10 equal parts. The percentage distribution of urinary stone types and biochemical parameters of urine and blood were determined in each range. Results. As magnesiuria increased, the proportion of calcium oxalate stones among male patients increased 2.0-2.7 times (p=0.0001), the frequency of detection of oxalate stones increased 1.7 times (p=0.009), in contrast to women. In women, the proportion of carbonate apatite stones increased 2.0-4.0 times (p=0.025), and the frequency of detection of phosphate stones from carbonate apatite with increasing magnesiuria was 2.0 times higher than in men (p=0.001). In men, an increase in magnesium excretion was accompanied by an increase in the frequency of detection of calcium stones by 1.6-2.0 times (p<0.025) and there was a direct correlation between magnesiuria and the frequency of detection of calcium stones (rs = 0.700, p = 0.036), in contrast to women. However, women showed high activity of carbonatapatite lithogenesis, which was almost 2-3 times higher than that of men (p <0.0001). Magnesiuria in women negatively correlated with the frequency of detection of carbonatapatite stones (r= -0.704, p=0.034) and the pH of urine (r= -0.900, p=0.0009). In men, there was no noticeable effect of increasing magnesiuria on the frequency of detection of uric acid stones, whereas in women, there was a 2.2-2.8-fold increase in the frequency of detection of uric acid stones (p<0.04). In patients of both sexes, an increase in magnesiuria was accompanied by a decrease in the incidence of struvite stones, apparently due to acidification of urine, due to the existence of an inverse correlation between magnesiuria and urine pH values (in women rs = 0.783, p = 0.013; in men rs = -0.733, p = 0.025). Compared with women, there was an increase in the proportion of male patients with oxalate stones in the age groups 18-29yr (2.5 times, p=0.0023) and 50-59yr (2.15 times, p<0.0001), indicating the association of magnesiuria with oxalate lithogenesis. At the same time, there was no noticeable effect of magniuria on carbonatapatite lithogenesis. Conclusion. Magnesiuria has a certain modifying effect on the lithogenesis of oxalate stones, uric acid stones, phosphate (carbonatapatite) and calcium oxalate-phosphate stones. In stone formers men and women, the nature of this effect has its own characteristics. With magnesiuria above 3.0 mM/day, the relative risk of developing oxalate and carbonatapatite stones in men is increased, and the risk of phosphate lithogenesis in women is reduced. The lithogenic properties of magnesiuria are largely able to manifest themselves due to the involvement of other lithogenic factors in the process of stone formation, such as calciuria and/or shifts in urine pH. what should be considered when conducting personalized anti-recurrence treatment (metaphylaxis) of urolithiasis.
- 25 December 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (4)
Metabolic risk factors and urinary stones formation. XI: magnesiuria lithogenic features in men and women.
Introduction. The role of magnesiuria as a metabolic factor in the lithogenesis of both calcium stones and separately oxalate and phosphate urinary stones, as well as stones of other metabolic types, remains unclear. In this work, we investigated the effect of the degree of magnesium excretion in men and women with urolithiasis on metabolic parameters and the frequency of detection of urinary stones of various chemical compositions. Materials and methods. 865 stone formers (392 men and 473 women aged 18 to 79 years) were examined. To assess the lithogenic activity of magnesiuria in stone formers men and women, the values of magnesium excretion (in mmol/day) were ranked in ascending order and divided into 10 equal parts. The percentage distribution of urinary stone types and biochemical parameters of urine and blood were determined in each range. Results. As magnesiuria increased, the proportion of calcium oxalate stones among male patients increased 2.0-2.7 times (p=0.0001), the frequency of detection of oxalate stones increased 1.7 times (p=0.009), in contrast to women. In women, the proportion of carbonate apatite stones increased 2.0-4.0 times (p=0.025), and the frequency of detection of phosphate stones from carbonate apatite with increasing magnesiuria was 2.0 times higher than in men (p=0.001). In men, an increase in magnesium excretion was accompanied by an increase in the frequency of detection of calcium stones by 1.6-2.0 times (p<0.025) and there was a direct correlation between magnesiuria and the frequency of detection of calcium stones (rs = 0.700, p = 0.036), in contrast to women. However, women showed high activity of carbonatapatite lithogenesis, which was almost 2-3 times higher than that of men (p <0.0001). Magnesiuria in women negatively correlated with the frequency of detection of carbonatapatite stones (r= -0.704, p=0.034) and the pH of urine (r= -0.900, p=0.0009). In men, there was no noticeable effect of increasing magnesiuria on the frequency of detection of uric acid stones, whereas in women, there was a 2.2-2.8-fold increase in the frequency of detection of uric acid stones (p<0.04). In patients of both sexes, an increase in magnesiuria was accompanied by a decrease in the incidence of struvite stones, apparently due to acidification of urine, due to the existence of an inverse correlation between magnesiuria and urine pH values (in women rs = 0.783, p = 0.013; in men rs = -0.733, p = 0.025). Compared with women, there was an increase in the proportion of male patients with oxalate stones in the age groups 18-29yr (2.5 times, p=0.0023) and 50-59yr (2.15 times, p<0.0001), indicating the association of magnesiuria with oxalate lithogenesis. At the same time, there was no noticeable effect of magniuria on carbonatapatite lithogenesis. Conclusion. Magnesiuria has a certain modifying effect on the lithogenesis of oxalate stones, uric acid stones, phosphate (carbonatapatite) and calcium oxalate-phosphate stones. In stone formers men and women, the nature of this effect has its own characteristics. With magnesiuria above 3.0 mM/day, the relative risk of developing oxalate and carbonatapatite stones in men is increased, and the risk of phosphate lithogenesis in women is reduced. The lithogenic properties of magnesiuria are largely able to manifest themselves due to the involvement of other lithogenic factors in the process of stone formation, such as calciuria and/or shifts in urine pH. what should be considered when conducting personalized anti-recurrence treatment (metaphylaxis) of urolithiasis.
- Open Access
- 25 December 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (4)
The incidence of calcium oxalate stones in varions metabolic conditions.
Introduction. The lithogenesis of calcium oxalate stones largely depends on specific metabolic disturbances, which develop under the influence of various endogenous, exogenous, and social factors. To prevent recurrence of the disease, according to the Russian Ministry of Health's clinical guidelines for «Urolithiasis», it is necessary to focus on the levels of lithogenic substances in the blood and daily urine. However, these standard values considered without taking into account their potential to cause the development of urinary stones of a specific chemical composition. Determining such laboratory criteria may help clinicians more reliably prevent the development of urolithiasis. The aim of this study was to investigate the metabolic conditions underlying the formation of calcium oxalate stones. Materials and methods. Data from 263 patients (145 men, 118 women) with calcium oxalate stones (>50% of stone composition) aged 18 to 78 years, treated at the N.A. Lopatkin Research Institute of Urology and Interventional Radiology from 2019 to 2023 analyzed. Biochemical analysis of 24-hour urine used to determine levels of calcium, uric acid, phosphorus, magnesium, and pH. Each dependent variable ranked by interval. Results. The greatest lithogenic effect on the formation of calcium oxalate stones observed when the threshold values are exceeded: calcium 4.8-5.1 mmol/day, uric acid 3.48-3.87 mmol/day (non-linear graph), phosphates 34.4-40.2 mmol/day, magnesium 5.4-6.4 mmol/day and urine pH 4.8-5.5. The following excretion parameters were less significant: calcium up to 3.8-4.35 mmol/day, uric acid - 0.7-1.71 mmol/day, phosphates - up to 34.2 mmol/day, magnesium 0.20-1.49 mmol/day and urine pH 7.1-9.0. Conclusion. The most significant metabolic conditions for calcium oxalate stone formation are: urinary calcium excretion above 5.8-5.1 mmol/day and urine pH less than 6.0. The highest incidence of wewellite and weddelite observed at pH values of 4.8-5.5 and 5.6-6.0, respectively. Given the influence of urine pH on calcium excretion, correction of urine pH plays a key role in the prevention of calcium oxalate lithogenesis
- 25 December 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (4)
Open AccessThe incidence of calcium oxalate stones in varions metabolic conditions.
Introduction. The lithogenesis of calcium oxalate stones largely depends on specific metabolic disturbances, which develop under the influence of various endogenous, exogenous, and social factors. To prevent recurrence of the disease, according to the Russian Ministry of Health's clinical guidelines for «Urolithiasis», it is necessary to focus on the levels of lithogenic substances in the blood and daily urine. However, these standard values considered without taking into account their potential to cause the development of urinary stones of a specific chemical composition. Determining such laboratory criteria may help clinicians more reliably prevent the development of urolithiasis. The aim of this study was to investigate the metabolic conditions underlying the formation of calcium oxalate stones. Materials and methods. Data from 263 patients (145 men, 118 women) with calcium oxalate stones (>50% of stone composition) aged 18 to 78 years, treated at the N.A. Lopatkin Research Institute of Urology and Interventional Radiology from 2019 to 2023 analyzed. Biochemical analysis of 24-hour urine used to determine levels of calcium, uric acid, phosphorus, magnesium, and pH. Each dependent variable ranked by interval. Results. The greatest lithogenic effect on the formation of calcium oxalate stones observed when the threshold values are exceeded: calcium 4.8-5.1 mmol/day, uric acid 3.48-3.87 mmol/day (non-linear graph), phosphates 34.4-40.2 mmol/day, magnesium 5.4-6.4 mmol/day and urine pH 4.8-5.5. The following excretion parameters were less significant: calcium up to 3.8-4.35 mmol/day, uric acid - 0.7-1.71 mmol/day, phosphates - up to 34.2 mmol/day, magnesium 0.20-1.49 mmol/day and urine pH 7.1-9.0. Conclusion. The most significant metabolic conditions for calcium oxalate stone formation are: urinary calcium excretion above 5.8-5.1 mmol/day and urine pH less than 6.0. The highest incidence of wewellite and weddelite observed at pH values of 4.8-5.5 and 5.6-6.0, respectively. Given the influence of urine pH on calcium excretion, correction of urine pH plays a key role in the prevention of calcium oxalate lithogenesis
- Open Access
- 28 November 2025
- Published by Vidar, Ltd. in Medical Visualization
- Vol. 29 (4) , 107-119
Retrospective Analysis of MRI Data in Patients Undergoing Fusion Biopsy of the Prostate
To investigate the causes of low diagnostic accuracy of MRI criteria for prostate cancer by correlation with histopathological findings from MRI-targeted fusion biopsy. Materials and methods. A retrospective analysis of prostate MRI data was performed in 38 patients who subsequently underwent MRI-targeted fusion biopsy. All imaging studies were independently reviewed by a radiologist with 7 years of experience in prostate imaging. Identified suspicious lesions were correlated with histopathological findings from corresponding prostate biopsy samples. The causes of discordant results were systematically analyzed and categorized. Results. The MRI studies identified 54 MRI-positive lesions that subsequently underwent fusion biopsy. Among these, 34 cases demonstrated false-positive MRI findings attributed to the following causes: localized inflammation exhibiting T2-weighted hypointensity, restricted diffusion, and early contrast enhancement (16 cases, including wedge-shaped lesions); encapsulated hyperplastic nodules (7 cases); and minimal lesion size (3 cases). Two cases resulted from overinterpretation of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) MRI data. Systematic biopsy revealed adenocarcinoma in 24 tissue samples obtained from areas not identified as suspicious on MRI (false-negative results). Retrospective analysis of MRI findings allowed detection of subtle abnormalities in only one of these cases. The MRI demonstrated a sensitivity of 45% and positive predictive value of 37%. Conclusion. The study results revealed substantial subjectivity in MRI data interpretation for prostate cancer diagnosis. Overdiagnosis of tumorous changes was significant, with false-positive rates of 55% in the peripheral zone (PZ) and 72% in the transition zone (TZ). The highest proportion of errors (76%) occurred in PI-RADS category 3 lesions, where 26 out of 34 false-positive findings were associated with this group. The primary cause of misdiagnosis (32% of cases) was morphologic changes caused by diffuse or localized inflammation mimicking tumor features: hypointensity on T2-weighted imaging (T2WI), restricted diffusion, and early enhancement on dynamic contrast-enhanced (DCE) MRI. In 21% of TZ cases, errors were related to insufficient attention to the complete encapsulation sign of suspicious nodules, which can be confirmed through sequential analysis of T2WI on adjacent slices. An additional 15% of false-positive results in the PZ occurred due to underestimation of wedge-shaped lesion morphology, a key differential diagnostic feature. These findings highlight the need for standardized MRI evaluation criteria, detailed analysis of lesion characteristics, and incorporation of clinical inflammation data to reduce overdiagnosis.
- 28 November 2025
- Published by Vidar, Ltd. in Medical Visualization
- Vol. 29 (4) , 107-119
Open AccessRetrospective Analysis of MRI Data in Patients Undergoing Fusion Biopsy of the Prostate
To investigate the causes of low diagnostic accuracy of MRI criteria for prostate cancer by correlation with histopathological findings from MRI-targeted fusion biopsy. Materials and methods. A retrospective analysis of prostate MRI data was performed in 38 patients who subsequently underwent MRI-targeted fusion biopsy. All imaging studies were independently reviewed by a radiologist with 7 years of experience in prostate imaging. Identified suspicious lesions were correlated with histopathological findings from corresponding prostate biopsy samples. The causes of discordant results were systematically analyzed and categorized. Results. The MRI studies identified 54 MRI-positive lesions that subsequently underwent fusion biopsy. Among these, 34 cases demonstrated false-positive MRI findings attributed to the following causes: localized inflammation exhibiting T2-weighted hypointensity, restricted diffusion, and early contrast enhancement (16 cases, including wedge-shaped lesions); encapsulated hyperplastic nodules (7 cases); and minimal lesion size (3 cases). Two cases resulted from overinterpretation of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) MRI data. Systematic biopsy revealed adenocarcinoma in 24 tissue samples obtained from areas not identified as suspicious on MRI (false-negative results). Retrospective analysis of MRI findings allowed detection of subtle abnormalities in only one of these cases. The MRI demonstrated a sensitivity of 45% and positive predictive value of 37%. Conclusion. The study results revealed substantial subjectivity in MRI data interpretation for prostate cancer diagnosis. Overdiagnosis of tumorous changes was significant, with false-positive rates of 55% in the peripheral zone (PZ) and 72% in the transition zone (TZ). The highest proportion of errors (76%) occurred in PI-RADS category 3 lesions, where 26 out of 34 false-positive findings were associated with this group. The primary cause of misdiagnosis (32% of cases) was morphologic changes caused by diffuse or localized inflammation mimicking tumor features: hypointensity on T2-weighted imaging (T2WI), restricted diffusion, and early enhancement on dynamic contrast-enhanced (DCE) MRI. In 21% of TZ cases, errors were related to insufficient attention to the complete encapsulation sign of suspicious nodules, which can be confirmed through sequential analysis of T2WI on adjacent slices. An additional 15% of false-positive results in the PZ occurred due to underestimation of wedge-shaped lesion morphology, a key differential diagnostic feature. These findings highlight the need for standardized MRI evaluation criteria, detailed analysis of lesion characteristics, and incorporation of clinical inflammation data to reduce overdiagnosis.